Simultaneous mRNA COVID-19 and IIV4 Vaccination Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth Schlaudecker, MD, MPH
Children's Hospital Medical Center, Cincinnati
Principal Investigator - Emmanuel B Walter, MD, MPH
Duke University
Principal Investigator - Karen R Broder, MD
Centers for Disease Control and Prevention
Principal Investigator - Kawsar Talaat, MD
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- John Hopkins University
Baltimore, Maryland, United States
- Duke University
Durham, North Carolina, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Oct 2021
- Primary completion
- 3 Mar 2023
- Completion
- 15 Jun 2023
- Last update posted
- 19 Mar 2024
- Registered enrollment
- 348
- Registry id
- NCT05028361
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.